Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung

作者: Dai Hashimoto , Toshi Nagata , Masato Uchijima , Shintaro Seto , Takafumi Suda

DOI: 10.1016/J.VACCINE.2008.03.101

关键词:

摘要: The present study evaluates the potential of improved third-generation lentivirus vector with respect to their use as an in vivo-administered T-cell vaccine against tuberculosis. Intratracheal administration encoding MPT51 Mycobacterium tuberculosis could induce MPT51-specific CD8+ T cells mediastinal lymph nodes 2 weeks after administration. vaccination generate memory lung, but not nodes. Further, a single intratracheal immunization lentiviral decreased significantly number virulent M. lung challenge bacillus. These findings suggest that vaccines is promising strategy pulmonary

参考文章(37)
J. Rodrigo Mora, Guiying Cheng, Dominic Picarella, Michael Briskin, Natasha Buchanan, Ulrich H. von Andrian, Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. Journal of Experimental Medicine. ,vol. 201, pp. 303- 316 ,(2005) , 10.1084/JEM.20041645
S H E Kaufmann, Immunity to intracellular bacteria Annual Review of Immunology. ,vol. 11, pp. 129- 163 ,(1993) , 10.1146/ANNUREV.IY.11.040193.001021
Tom Dull, Romain Zufferey, Michael Kelly, R. J. Mandel, Minh Nguyen, Didier Trono, Luigi Naldini, A Third-Generation Lentivirus Vector with a Conditional Packaging System Journal of Virology. ,vol. 72, pp. 8463- 8471 ,(1998) , 10.1128/JVI.72.11.8463-8471.1998
Maria Fe Medina, Gary P Kobinger, John Rux, Mehdi Gasmi, David J Looney, Paul Bates, James M Wilson, Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung Molecular Therapy. ,vol. 8, pp. 777- 789 ,(2003) , 10.1016/J.YMTHE.2003.07.003
Robert J. Hogan, Weimin Zhong, Edward J. Usherwood, Tres Cookenham, Alan D. Roberts, David L. Woodland, Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. Journal of Experimental Medicine. ,vol. 193, pp. 981- 986 ,(2001) , 10.1084/JEM.193.8.981
I. N. Guedes, L. C. Rodrigues, J. A. C. Sterne, Does the efficacy of BCG decline with time since vaccination International Journal of Tuberculosis and Lung Disease. ,vol. 2, pp. 200- 207 ,(1998)
Stefan H. E. Kaufmann, Is the development of a new tuberculosis vaccine possible Nature Medicine. ,vol. 6, pp. 955- 960 ,(2000) , 10.1038/79631
Ananda W. Goldrath, Michael J. Bevan, Stefan Martin, Peter Brossart, Eric A. Butz, Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. Journal of Immunology. ,vol. 158, pp. 3270- 3276 ,(1997)
Jun Wang, Lisa Thorson, Richard W Stokes, Michael Santosuosso, Kris Huygen, Anna Zganiacz, Mary Hitt, Zhou Xing, None, Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis Journal of Immunology. ,vol. 173, pp. 6357- 6365 ,(2004) , 10.4049/JIMMUNOL.173.10.6357